Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study - Test2 - elhamkhani - TriplyDB

Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study

Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study

http://www.wikidata.org/entity/Q33655366

about

Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatment Preclinical molecular imaging of tumor angiogenesis.Multispectral fluorescence ultramicroscopy: three-dimensional visualization and automatic quantification of tumor morphology, drug penetration, and antiangiogenic treatment response In vivo, dual-modality OCT/LIF imaging using a novel VEGF receptor-targeted NIR fluorescent probe in the AOM-treated mouse model.Imaging key biomarkers of tumor angiogenesis Biomarkers for tyrosine kinase inhibitors in renal cell cancer.Positron emission tomography tracers for imaging angiogenesis.Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.Clinical applications in molecular imaging.Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.SLT-VEGF reduces lung metastases, decreases tumor recurrence, and improves survival in an orthotopic melanoma model.Preparation and evaluation of a 68Ga-labeled RGD-containing octapeptide for noninvasive imaging of angiogenesis: biodistribution in non-human primate.

P2860

Q28073057-D9065A93-5585-4A0B-9A3B-40AE6E9A97B2 Q30475818-38271827-7A01-4264-8AE1-63CE0ADBA90D Q30571893-D6AB94C6-6523-40C1-804C-55360DED6D36 Q33736042-FDC4E4B0-9290-47C9-A45D-673A3B2F1078 Q35999557-F1F63323-07D6-48B3-9607-38772D0459EC Q36450612-70B49C80-CFF6-4374-9E6D-4AE1B86BF1B2 Q36777285-ABA68CB5-06AD-4E7B-95DF-9291F1D391A6 Q37054876-059DFE74-9F24-41CB-A284-5CFC5FAB2C84 Q37815405-39901AD8-F9E2-4182-8027-38755E8737AF Q38734446-112CD384-4C21-4938-8D69-28597D5ACCAA Q39661859-64D91392-23F0-4067-A524-E5C4F56CE66B Q55098453-763AFB17-2085-436A-8166-9A97895140A7

P2860

Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study

http://www.wikidata.org/entity/Q33655366

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Noninvasive assessment of tumo ...... nib: a molecular imaging study

@ast

Noninvasive assessment of tumo ...... nib: a molecular imaging study

@en

type

label

Noninvasive assessment of tumo ...... nib: a molecular imaging study

@ast

Noninvasive assessment of tumo ...... nib: a molecular imaging study

@en

prefLabel

Noninvasive assessment of tumo ...... nib: a molecular imaging study

@ast

Noninvasive assessment of tumo ...... nib: a molecular imaging study

@en

P1433

Q33655366-C41CCE4D-9205-4FE1-B2F6-254DBAC50AD9

P1476

Q33655366-309B7EB6-F7DC-4232-839B-5C7E2F226857

P2093

Q33655366-152CF82B-BC4F-443C-8A78-A38E6397CC21

Q33655366-1DF1D348-108E-44C4-BAD8-949790264E71

Q33655366-28E37C1B-EB4D-4098-BEFE-D4BF532D4A04

Q33655366-365DA2EA-E395-4559-B319-302EB30EBCDD

Q33655366-3C09F0D4-FF2C-4A39-990C-B06847D23E9F

Q33655366-AE8F0E47-AEFC-40C2-BED4-B140CE7695B7

P2860

Q33655366-03DE7265-A489-427B-B291-085922A9E21B

Q33655366-08251C8A-D134-4BA2-940A-E0071BA0CB6C

Q33655366-0C1C1477-7CAD-499B-B66A-9143FEF676F8

Q33655366-16E5C714-3372-4925-A23C-58667BCBDFBD

Q33655366-1779D863-1C57-4D2B-B9C8-41174439A479

Q33655366-1A525E1F-9B85-4C35-BE2E-866E5084FE22

Q33655366-239ADDD1-CDEB-4974-B408-DC9FC43C2BA0

Q33655366-253B3979-FDD8-43B5-B034-6C3F6E27CFA7

Q33655366-2F4A477C-B38F-4DE8-BDC2-0B31E0037AB1

Q33655366-3E2D1651-91DF-4FD6-93A3-0F97DBDFE52D

P304

Q33655366-7FFE66AA-0D39-46F3-81C9-9D9AABBEFD7F

P31

Q33655366-FB0BBB5B-3E21-48EF-AE2F-5F12D0E723EB

P356

Q33655366-BFF97D07-AEE1-4CD0-AAD8-24C9B6755885

P433

Q33655366-255643E6-17F9-487E-9E17-B750C840D728

P478

Q33655366-648E50ED-5347-44B6-96CD-A65DABD81AAF

P577

Q33655366-D7C959AA-B076-4BF4-8A72-ED9F831E2F8A

P5875

Q33655366-BC4B3319-592D-420B-8492-374DF2C69173

P698

Q33655366-974DEF0D-74AA-4DCE-9A60-07A94E051B65

P932

Q33655366-A373900E-FD35-42F7-9A99-0552CA29B101

P356

P1433

Translational Oncology

P1476

Noninvasive assessment of tumo ...... nib: a molecular imaging study

@en

P2093

Francis G Blankenberg

http://www.w3.org/2001/XMLSchema#string

John Pizzonia

http://www.w3.org/2001/XMLSchema#string

Joseph M Backer

http://www.w3.org/2001/XMLSchema#string

Marina V Backer

http://www.w3.org/2001/XMLSchema#string

Susanta K Sarkar

http://www.w3.org/2001/XMLSchema#string

Zoia Levashova

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization

Cutting off cancer's supply lines

Modes of resistance to anti-angiogenic therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab.

Validation of novel imaging methodologies for use as cancer clinical trial end-points

P304

56-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/TLO.09271

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41467235

http://www.w3.org/2001/XMLSchema#string

P698

20165696

http://www.w3.org/2001/XMLSchema#string

P932

2822454

http://www.w3.org/2001/XMLSchema#string